Xuguang Song
Xuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Efferocytosis enhances macrophage pro-angiogenic functions for bone marrow regeneration.
Journal: Cell death and differentiation
Published: December 08, 2025
Targeting NLRP1-CCL8 axis in the leukaemic niche suppresses AML via inhibition of PI3K-AKT signalling.
Journal: British journal of haematology
Published: March 06, 2025
Dynamic assessment of myelofibrosis progression in myeloproliferative neoplasm mouse model using a minimally invasive evaluation system.
Journal: International immunopharmacology
Published: October 08, 2024
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma.
Journal: Clinical and experimental medicine
Published: July 07, 2024
Clinicopathologic Features and Genomic Signature of De Novo CD5 + Diffuse Large B-Cell Lymphoma : A Multicenter Collaborative Study.
Journal: The American journal of surgical pathology
Published: August 25, 2022
Disparity Analysis of Clinicopathologic Hallmarks between Transformed DLBCL and Primary DLBCL.
Journal: Clinical laboratory
Published: August 17, 2022
Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma.
Journal: Frontiers in immunology
Published: January 19, 2022
A Novel Prognostic Index Model for Adult Hemophagocytic Lymphohistiocytosis: A Multicenter Retrospective Analysis in China.
Journal: Frontiers in immunology
Published: December 06, 2021
l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
Journal: Journal of biochemical and molecular toxicology
Published: September 24, 2021
Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
Journal: Frontiers in immunology
Published: August 09, 2021
The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma.
Journal: Anti-cancer agents in medicinal chemistry
Published: April 02, 2021
Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era.
Journal: International journal of hematology
Published: January 20, 2021
Last Updated: 09/26/2026